Regime of Use of Rituximab in Patients with Rheumatoid Arthritis in Daily Clinical Practice.

被引：0
|
作者：
Merino-Melendez, Leticia [1 ]
Llorente, Irene [1 ]
Castaneda, Santos [2 ]
Velasco, Teresa [1 ]
Sala-Icardo, Luis [3 ]
Garcia-Vicuna, Rosario [3 ]
Garcia-Vadillo, Alberto [1 ]
Lopez-Bote, Juan P. [3 ]
Lopez-Lopez, Jorge [1 ]
Herrera, Federico [1 ]
Munoz-Calleja, Cecilia [1 ]
Alvaro-Gracia, J. M. [1 ]
Gonzalez-Alvaro, Isidoro [3 ]
机构：
[1] Hosp Univ La Princesa, Madrid, Spain
[2] Hosp Univ La Princesa, IISP, Madrid, Spain
[3] Hosp Univ La Princesa, IIS La Princesa, Madrid, Spain
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2412
引用
收藏
页码：S1051 / S1052
页数：2
相关论文
共 50 条
  • [11] Adherence to treatment with tofacitinib in patients with rheumatoid arthritis in daily clinical practice
    Barbich, Tatiana
    Cerda, Osvaldo Luis
    Schneeberger, Emilce Edith
    Citera, Gustavo
    REUMATOLOGIA CLINICA, 2020, 18 (03): : 164 - 168
  • [12] Recommendations on the use of rituximab for patients with rheumatoid arthritis
    Rubbert-Roth, A.
    Burmester, G.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2008, 67 (07): : 609 - 613
  • [13] Recommendations for use of rituximab in patients with rheumatoid arthritis
    Rubbert-Roth, A.
    Burmester, G. R.
    Doerner, T.
    Gause, A.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (02): : 165 - +
  • [14] Cumulative Clinical Response in Rheumatoid Arthritis Patients with Rituximab Repeated Courses after Failure to Tumor Necrosis Factor Inhibitors in Routine Clinical Practice.
    Codreanu, Catalin
    Ionescu, Ruxandra
    Ancuta, Ioan
    Mogosan, Corina
    Rednic, Simona
    Ciurea, Paulina
    Suta, Maria
    Parvu, Magda
    Balanescu, Andra
    Bojinca, Mihai
    Nemes, Dan
    Ancuta, Codrina
    Rezus, Elena
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S671 - S672
  • [15] ACT-LIFE STUDY: PATTERNS OF TOCILIZUMAB USE, AND DOSING AMONG PATIENTS WITH RHEUMATOID ARTHRITIS IN THE CLINICAL PRACTICE.
    Tovar Beltran, J. V.
    Guzman Ubeda, M. A.
    Mateo Bernardo, I.
    Garcia-Vicuna, R.
    Rodriguez-Gomez, M.
    Belmonte-Serrano, M.
    Marras, C.
    Loza Cortina, E.
    Perez Pampin, E.
    Vila, V.
    Balsa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 456 - 456
  • [16] Efficacy of rituximab in patients with rheumatoid arthritis refractory or with contra-indication to anti-tumor necrosis factor-alpha drugs in daily practice.
    Assous, Noemie
    Gossec, Laure
    Dougados, Maxime
    Kahan, Andre
    Allanore, Yannick
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S234 - S234
  • [17] THE BEST SELECTION OF SECOND BIOLOGICS FOR PATIENTS WITH RHEUMATOID ARTHRITIS IN DAILY CLINICAL PRACTICE
    Saito, K.
    Nakano, K.
    Nakayamada, S.
    Kubo, S.
    Miyagawa, I.
    Hirata, S.
    Tanaka, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 513 - 513
  • [18] Prevalence of biologics monotherapy in a cohort of patients with Rheumatoid Arthritis in daily clinical practice
    Erika Catay
    Maximiliano Bravo
    Javier Rosa
    Enrique R. Soriano
    BMC Musculoskeletal Disorders, 17
  • [19] SAFETY OF JAK INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CONDITIONS OF DAILY CLINICAL PRACTICE
    Cid Boza, Natalia
    Velloso Feijoo, M. L.
    Nahia, Plaza
    Luis Marenco, Jose
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1681 - 1682
  • [20] Long-term Use of Golimumab in Daily Practice for Patients with Rheumatoid Arthritis
    Nemoto, Tetsuya
    Ito, Satoshi
    Kobayashi, Daisuke
    Takai, Chinatsu
    Sakai, Syunsuke
    Kurosawa, Youichi
    Hasegawa, Eriko
    Okabayashi, Ryo
    Abe, Asami
    Otani, Hiroshi
    Lee, Hyunho
    Murasawa, Akira
    Narita, Ichiei
    Nakazono, Kiyoshi
    Toyoshima, Yoich
    Inagaki, Katunori
    Ishikawa, Hajime
    INTERNAL MEDICINE, 2021, 60 (09) : 1359 - 1367
12345